CYP2C19 Genotyping May Aid Antiplatelet Prescribing
WEDNESDAY, Sept. 9, 2020 -- Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 9, 2020 Category: Pharmaceuticals Source Type: news

International registries show PCI rates increased in Japan, US
(American College of Cardiology) Japan and the US have seen an increase in percutaneous coronary intervention (PCI) procedures, which is driven primarily by a rise in elective PCIs in Japan compared to non-elective in the U.S., according to a study in the Journal of the American College of Cardiology. Since adoption of large-scale PCI trial results vary internationally, the study sought to analyze large national registries in both countries to illuminate international variation in PCI practice as a foundation for further quality improvement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 7, 2020 Category: International Medicine & Public Health Source Type: news

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction, Heart
Study (n=34,127) found decline by 43% in the number of PCI procedures for STEMI in April 2020 vs the average between 2017 and 2019, but the in-hospital mortality rate was not higher during the lockdown (3.5% vs 4.8% before the lockdown). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 3, 2020 Category: Consumer Health News Source Type: news

Largest pharmacogenetic clinical trial in cardiology shows potential benefit in individualized approach to anti-platelet therapy
ROCHESTER, Minn. ? Heart patients who undergo percutaneous coronary intervention (PCI) or stent placement? nonsurgical procedures to improve blood flow to the heart ? are typically prescribed anti-platelet therapy to avoid blood clots that can lead to a heart attack or stroke. New research from the international TAILOR-PCI trial, the largest pharmacogenetics clinical trial in [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - August 25, 2020 Category: Hospital Management Source Type: news

Black patients have higher rates of death after PCI
(American College of Cardiology) Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to white patients, according to a study published today in JACC: Cardiovascular Interventions. The study underscores the high rates of cardiovascular disease and risk factors in minorities and continued need for further research on race-based outcomes after cardiovascular procedures, including PCI, to understand and alleviate these differences. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 6, 2020 Category: International Medicine & Public Health Source Type: news

New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages
-- Using optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI), physicians were able to select the right size stents and place them with greater precision (Source: Abbott.com)
Source: Abbott.com - June 26, 2020 Category: Pharmaceuticals Source Type: news

Medtronic Expands Indications for the Resolute Onyx DES in Europe
Medtronic has scored CE mark for a unique indication for the Resolute Onyx drug-eluting stent. The Dublin-based company said the approval was for a DAPT indication for high bleeding risk (HBR) patients. The firm said for HBR patients whose bleeding risk may be increased by taking longer DAPT regimens (a combination of aspirin and anti-clotting medication), this new, indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx. The indication is based on results from the Onyx ONE Global Study, a prospective, randomized, one-month DAPT...
Source: MDDI - June 8, 2020 Category: Medical Devices Authors: MDDI Staff Tags: Regulatory and Compliance Cardiovascular Source Type: news

Abiomed Granted IDE to Evaluate ‘World’s Smallest Heart Pump’
Abiomed said it has received approval for an IDE to start an early feasibility study of what it is calling the “world’s smallest heart pump.”   The Danvers, MA-based company said the first-in-human trial will look at the 9 French Impella ECP heart pump in high-risk percutaneous coronary intervention (PCI) patients.   The primary endpoint of the study is successful delivery, initiation, and maintenance of adequate hemodynamic support and a composite rate of major device-related adverse events during high-risk PCI.   The stu...
Source: MDDI - June 6, 2020 Category: Medical Devices Tags: Cardiovascular Regulatory and Compliance Source Type: news

Primary PCI Remains Standard of Care for STEMI During COVID-19
WEDNESDAY, April 29, 2020 -- Primary percutaneous coronary intervention (PCI) remains the standard of care for patients with ST-elevation myocardial infarction (STEMI) during the COVID-19 pandemic, according to a consensus statement published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 29, 2020 Category: Pharmaceuticals Source Type: news

CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock CABG Tied to Lower Death Rate in MI Complicated by Cardiogenic Shock
Coronary-artery-bypass grafting (CABG) is associated with lower in-hospital mortality in myocardial infarction (MI) complicated by cardiogenic shock, compared with percutaneous coronary intervention (PCI), according to a database study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 7, 2020 Category: Surgery Tags: Cardiology News Source Type: news

TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes TWILIGHT Benefits of Dropping Aspirin Hold Up in Diabetes
Treatment with ticagrelor alone shows no increase in bleeding, MI, or stroke after percutaneous coronary intervention in the TWILIGHT trial subanalysis.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 1, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Genetic testing for antiplatelet therapy post-PCI misses cut in cardiovascular events
(American College of Cardiology) An international clinical trial that used genetic testing to guide which antiplatelet medication was given to patients following percutaneous coronary intervention (PCI) did not meet its stated goal for cutting in half the incidence of serious adverse cardiovascular events, such as heart attack and stroke, in the year following the procedure, according to study results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 30, 2020 Category: Biology Source Type: news

Location of Coronary-artery Lesion Not Tied to Stenting Outcome Location of Coronary-artery Lesion Not Tied to Stenting Outcome
The outcomes of percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DES) in patients with proximal left anterior descending (P-LAD) coronary-artery lesions appear similar to those seen in patients with lesions in other segments, according to data from three clinical trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
MONDAY, March 16, 2020 -- For patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy is associated with a reduced risk for bleeding compared with triple therapy, according to research published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news

Cracking (the Code of) CAC to Win the Last Battle of PCI Cracking (the Code of) CAC to Win the Last Battle of PCI
A new study elucidates the underlying mechanism for an increased risk when treating calcified lesions during percutaneous coronary intervention with newer generation drug-eluting stents.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

2003 to 2016 Saw Changes in Characteristics of PCI, CABG Patients
MONDAY, March 2, 2020 -- Between 2003 and 2016, there were decreases in in-hospital mortality after coronary artery bypass grafting (CABG) but not after percutaneous coronary intervention (PCI), according to a study published online Feb. 14 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2020 Category: Pharmaceuticals Source Type: news

Philips Seeks Better Understanding of PCI Outcomes Through New Trial
Philips is continuing its investment into percutaneous coronary intervention (PCI) procedures through a new study. The company announced the (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) (DEFINE GPS) global multicenter study, which has a goal to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images. The announcement of the study comes on the heels of Philips making a bid to shed its appliances unit so it can focus on healthcare.  The primary endpoint is target vessel failure (a composite o...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news

Polymer-Based Stents Noninferior for Patients With High Bleeding Risk
THURSDAY, Feb. 20, 2020 -- Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention (PCI), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2020 Category: Pharmaceuticals Source Type: news

Biodegradable Coronary Stents Better Than Durable Stents in Registry Study Biodegradable Coronary Stents Better Than Durable Stents in Registry Study
Patients with acute myocardial infarction (MI) who underwent percutaneous coronary intervention (PCI) had better outcomes with biodegradable polymer drug-eluting stents (BP-DES) than with second-generation durable polymer drug-eluting stents (DP-DES), a South Korean registry study found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Clopidogrel Appropriate for PCI in Liver Transplant Candidates Clopidogrel Appropriate for PCI in Liver Transplant Candidates
In patients with decompensated cirrhosis undergoing percutaneous coronary intervention (PCI), clopidogrel safely inhibits platelet aggregation, according to a small study of liver-transplant candidates.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 8, 2020 Category: Surgery Tags: Cardiology News Source Type: news

Percutaneous Coronary Intervention (PCI)
Title: Percutaneous Coronary Intervention (PCI)Category: Procedures and TestsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 1/3/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 3, 2020 Category: Cardiology Source Type: news

Welcome Data Show Two Sides of PCI in Patients With Cancer Welcome Data Show Two Sides of PCI in Patients With Cancer
Although more patients with cancer are living longer and are undergoing percutaneous coronary intervention, data are scarce on contemporary stent performance.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - December 31, 2019 Category: Surgery Tags: Cardiology News Source Type: news

University Hospital Giessen Performs First Minimally Invasive, Robotic-Assisted Coronary Intervention in Germany
The University Hospital Giessen is the first hospital in Germany where a robotic system assists in a minimally invasive procedure to place a stent into a narrowed coronary artery to reopen it. This percutaneous coronary intervention (PCI) was carried out by the team of Prof. Holger Nef, Deputy Clinical Director Medical Clinic I, Cardiology and Angiology, University Giessen. (Source: eHealth News EU)
Source: eHealth News EU - December 18, 2019 Category: Information Technology Tags: Featured Siemens Healthineers Business and Industry Source Type: news

Can 3D Modeling Replace a Guidewire-Based Cardiac Procedure?
The CathWorks FFRangio System, which received FDA clearance in late last year, has just been approved by the Japan's Ministry of Health, Labour and Welfare (MHLW). Designed for use during angiography, the non-invasive diagnostic tool turns routine angiogram images into color-coded 3D renderings of blood flow in the heart's arteries. Physicians can then use the images to determine whether a stent is needed. “The CathWorks FFRangio System automatically receives the angiograms in DiCOM format from the C-ARM (X-Ray) systems at the time of angiogram procedure,” Ramin Mousavi, vice president,&...
Source: MDDI - December 17, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Cardiovascular Source Type: news

Many Patients Overestimate the Benefits of PCI
MONDAY, Dec. 9, 2019 -- Many patients do not understand or remember the information given to them during the informed consent process for percutaneous coronary intervention (PCI), according to a study published online Nov. 27 in the European Journal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2019 Category: Pharmaceuticals Source Type: news

AHA: Impella Use Up for PCI Patients Needing Heart Pump
THURSDAY, Nov. 21, 2019 -- Impella use is increasing for percutaneous coronary intervention (PCI) patients treated with mechanical circulatory support (MCS), although its use is associated with adverse events, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 21, 2019 Category: Pharmaceuticals Source Type: news

PCI, CABG for Left Main CAD Have Similar Five-Year Outcomes
FRIDAY, Oct. 4, 2019 -- Five-year rates of a composite outcome of death, stroke, and myocardial infarction are similar for patients with left main coronary artery disease following either percutaneous coronary intervention (PCI) or coronary artery... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2019 Category: Pharmaceuticals Source Type: news

Less Bleeding With Ticagrelor Alone in High-Risk Patients
FRIDAY, Sept. 27, 2019 -- Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2019 Category: Pharmaceuticals Source Type: news

Short DAPT After DES: P2Y12 Monotherapy in, Aspirin out! Short DAPT After DES: P2Y12 Monotherapy in, Aspirin out!
A new study addresses the question of when aspirin can be safely discontinued in higher risk patients such as those undergoing complex percutaneous coronary intervention.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 18, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Expert Alert: Study finds repeat coronary artery bypass grafting improves long-term survival
ROCHESTER, Minn. ?-- When a coronary artery bypass grafting (CABG) patient needs a second surgery because of recurrent chest pain, more often than not it's a percutaneous coronary intervention (PCI), commonly known as coronary angioplasty with stents. A study published in September in Mayo Clinic Proceedings says that a better option may be repeating the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 18, 2019 Category: Databases & Libraries Source Type: news

In STEMI, Biodegradable Polymer Sirolimus-Eluting Stents Superior
TUESDAY, Sept. 3, 2019 -- For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), there were fewer target lesion failures at one year in those receiving biodegradable polymer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2019 Category: Pharmaceuticals Source Type: news

Complete Revascularization Best for STEMI With Multivessel CAD
TUESDAY, Sept. 3, 2019 -- For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete revascularization is superior to culprit lesion-only percutaneous coronary intervention (PCI), according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 3, 2019 Category: Pharmaceuticals Source Type: news

Early after routine heart procedures, other operations become riskier
(Reuters Health) - Patients who have so-called percutaneous coronary intervention (PCI) procedures to restore blood flow to the heart may be more likely to have complications with non-cardiac surgery than other people, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 30, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Siemens Set to Jump into Robotics with Proposed Acquisition of Corindus
It looks like Siemens Healthineers is keen on diving into the medical robotics space. The Erlangen, Germany-based company said its subsidiary Siemens Medical Solutions is set to acquire Corindus Vascular Robotics for about $4.28 per share in cash or$1.1 billion. The transaction has been approved by Corindus’ board and is expected to close in 4Q19, subject to approval by the company’s stockholders. “Corindus has established a leading position in vascular robotics with a compelling technology platform for robotic-assisted coronary, peripheral, and neurovascular procedures...
Source: MDDI - August 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Imaging Source Type: news

Machine learning better predicts bleeding risk during coronary procedures
Machine learning techniques can better predict bleeding for patients undergoing percutaneous coronary intervention than other methods, report Yale researchers. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 22, 2019 Category: Universities & Medical Training Source Type: news

New Port Richey medical center performs first robotic-assisted procedure for arteries
The Medical Center of Trinity has successfully performed its first robotic-assisted angioplasty, which is the first for Tampa Bay and the first on Florida ’s west coast. The robotic tools help the physicians treat patients with coronary artery disease. Coronary artery disease, the plaque buildup that restricts blood flow in the arteries, is a widespread and life-threatening condition. Traditionally, percutaneous coronary intervention commonly kno wn as an ‘angioplasty,’ is the most common… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 3, 2019 Category: American Health Authors: Veronica Brezina-Smith Source Type: news

New Port Richey medical center performs first robotic-assisted procedure for arteries
The Medical Center of Trinity has successfully performed its first robotic-assisted angioplasty, which is the first for Tampa Bay and the first on Florida ’s west coast. The robotic tools help the physicians treat patients with coronary artery disease. Coronary artery disease, the plaque buildup that restricts blood flow in the arteries, is a widespread and life-threatening condition. Traditionally, percutaneous coronary intervention commonly kno wn as an ‘angioplasty,’ is the most common… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 3, 2019 Category: Biotechnology Authors: Veronica Brezina-Smith Source Type: news

Cardiac Arrest, Death During Elective PCI Concerningly Common Cardiac Arrest, Death During Elective PCI Concerningly Common
A European registry puts mortality at only about 50% if a patient arrests on the table during an elective percutaneous coronary intervention.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - June 4, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Open Heart Surgery Beats Stents for Multivessel Disease
FRIDAY, May 17, 2019 -- Coronary artery bypass graft (CABG) surgery may be a better treatment option than percutaneous coronary intervention (PCI) for most patients with more than one blocked heart artery, according to a study published online May 1... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2019 Category: Pharmaceuticals Source Type: news

Corindus Misses Expectations, But Still Embraced by Wall Street
Corindus Vascular Robotics missed earnings per share expectations by one cent, but Wall Street didn’t seem to mind as shares of the medtech company, which was a 2015 MDEA finalist, soared on Wednesday. At one-point shares were up by as much as 23%. The surgical robotics maker reported 1Q19 EPS of $0.05 against the analyst estimate of $0.04. Revenue for 1Q19 was $3 million vs. the consensus estimate of $3.11 million. The Waltham, MA-based company recorded purchase orders for 11 CorPath GRX Systems, an increase of 83% compared to purchase orders received in 4Q18 and 267% growth compared to the purchase orde...
Source: MDDI - May 8, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

PCI Beneficial for All Categories of Older AMI Patients
WEDNESDAY, April 24, 2019 -- For older patients with acute myocardial infarction (AMI), percutaneous coronary intervention (PCI) is beneficial across age strata, according to a research letter published online April 23 in Circulation: Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 24, 2019 Category: Pharmaceuticals Source Type: news

Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients Non-Adherence to Antiplatelet Therapy After PCI Ups Risk of MACE in Anemic Patients
In anemic patients who have undergone percutaneous coronary intervention (PCI), non-adherence to dual antiplatelet therapy (DAPT) - but not physician-recommended discontinuation - is associated with a higher risk of major adverse cardiovascular events (MACE) in the two years following the procedure, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 23, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Seniors Less Likely to Receive or Have Timely PCI for Acute MI
MONDAY, April 8, 2019 -- Seniors with acute myocardial infarction (AMI) are less likely to undergo percutaneous coronary intervention (PCI) or receive PCI in a timely manner, according to a study presented at the American Heart Association Quality... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2019 Category: Pharmaceuticals Source Type: news

Radial, femoral access for PCI found equal in terms of survival
(American College of Cardiology) Doctors can use either an artery in the arm (the radial approach) or in the groin (the femoral approach) to safely perform percutaneous coronary intervention (PCI) on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. The research, which was stopped early, suggests the radial and femoral approach are equivalent in terms of the risk of death at 30 days. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2019 Category: International Medicine & Public Health Source Type: news

CRF research to be presented at ACC.19
(Cardiovascular Research Foundation) Research from the Cardiovascular Research Foundation and the CRF Clinical Trials Center will be presented at the American College of Cardiology's 68th Annual Scientific Session taking place March 16-18, 2019 at the Ernest N. Morial Convention Center in New Orleans, Louisiana. They will be presenting the latest data on percutaneous coronary intervention (PCI), imaging technologies, renal denervation, and transcatheter aortic valve replacement. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2019 Category: International Medicine & Public Health Source Type: news

PCI in Stable Coronary Artery Disease: Still in Equipoise? PCI in Stable Coronary Artery Disease: Still in Equipoise?
The benefits of percutaneous coronary intervention remain controversial in patients with stable coronary artery disease. What insights does a recent study add?European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 11, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Transradial-Access CTO PCI Tied to Less Bleeding vs Other PCI Approaches (CME/CE)
(MedPage Today) -- Big shift in how centers perform chronic total occlusion percutaneous coronary intervention, large study shows (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 1, 2019 Category: Cardiology Source Type: news

Whatcom County Faces Challenges Despite Improvements Resulting from a Bundle of Care Approach to OHCA
Whatcom County, Washington, is the furthermost northwest county in the continental United States. The county covers over 2,200 square miles and has a population of approximately 250,000 people, of which 150,000 are within the city of Bellingham. Whatcom County is the state’s 12th largest county, part of which is only accessible by land through Canada. Whatcom County’s ALS program began in 1974. Over the years, the manner in which care has been delivered has steadily improved. In 1996, all BLS response units were equipped with an AED and a strong community effort to provide CPR training was initiated. Then, in ...
Source: JEMS Patient Care - February 27, 2019 Category: Emergency Medicine Authors: Marvin Wayne, MD, FACEP, FAAEM, FAHA Tags: Cardiac & Resuscitation Top Story Exclusive Articles Patient Care Heart of America Source Type: news

Medtronic Keeps DES Market Hot with New Indication
Rumblings in the Drug-Eluting Stent market continued this week after Medtronic said it has obtained FDA approval for an additional indication for its Resolute DES platform and the Resolute Integrity. The Dublin-based company’s new indication is for the treatment of patients with coronary disease who have de novo chronic total occlusion (CTO), a complex vessel condition involving complete blockage of a coronary artery. CTO is considered more difficult to treat with percutaneous coronary intervention (PCI) due to a greater risk of complications. The expanded CTO indication was supported by data from the PER...
Source: MDDI - February 26, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

Postconditioning During PCI for STEMI Shows Delayed Benefits
THURSDAY, Feb. 7, 2019 -- The benefits of postconditioning (PostC) balloon inflations in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) may not be apparent immediately, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2019 Category: Pharmaceuticals Source Type: news